120 related articles for article (PubMed ID: 10336579)
1. Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil.
Tracy TS; Korzekwa KR; Gonzalez FJ; Wainer IW
Br J Clin Pharmacol; 1999 May; 47(5):545-52. PubMed ID: 10336579
[TBL] [Abstract][Full Text] [Related]
2. The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib.
Chen S; Li X; Li Y; He X; Bryant M; Qin X; Li F; Seo JE; Guo X; Mei N; Guo L
Toxicol Sci; 2023 Dec; 197(1):69-78. PubMed ID: 37788138
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo human metabolism and pharmacokinetics of S- and R-praziquantel.
Kapungu NN; Li X; Nhachi C; Masimirembwa C; Thelingwani RS
Pharmacol Res Perspect; 2020 Aug; 8(4):e00618. PubMed ID: 32700798
[TBL] [Abstract][Full Text] [Related]
4. The X-Ray Crystal Structure of the Human Mono-Oxygenase Cytochrome P450 3A5-Ritonavir Complex Reveals Active Site Differences between P450s 3A4 and 3A5.
Hsu MH; Savas U; Johnson EF
Mol Pharmacol; 2018 Jan; 93(1):14-24. PubMed ID: 29093019
[TBL] [Abstract][Full Text] [Related]
5. Interactions among cytochromes P450 in microsomal membranes: oligomerization of cytochromes P450 3A4, 3A5, and 2E1 and its functional consequences.
Davydov DR; Davydova NY; Sineva EV; Halpert JR
J Biol Chem; 2015 Feb; 290(6):3850-64. PubMed ID: 25533469
[TBL] [Abstract][Full Text] [Related]
6. Differences of Atomic-Level Interactions between Midazolam and Two CYP Isoforms 3A4 and 3A5.
Liu S; Zheng Q; Bai F
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836743
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of the homotropic cooperative binding of azamulin to human cytochrome P450 3A5.
Hsu MH; Johnson EF
J Biol Chem; 2022 May; 298(5):101909. PubMed ID: 35398097
[TBL] [Abstract][Full Text] [Related]
8. Specific N-demethylation of verapamil by cytochrome P450 from
Shen C; Liu H; Dai W; Liu X; Liu J; Yu B
Eng Life Sci; 2019 Apr; 19(4):292-301. PubMed ID: 32625009
[TBL] [Abstract][Full Text] [Related]
9. Mammalian cytochrome P450 enzymes catalyze the phenol-coupling step in endogenous morphine biosynthesis.
Grobe N; Zhang B; Fisinger U; Kutchan TM; Zenk MH; Guengerich FP
J Biol Chem; 2009 Sep; 284(36):24425-31. PubMed ID: 19561069
[TBL] [Abstract][Full Text] [Related]
10. A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds.
Sawayama AM; Chen MM; Kulanthaivel P; Kuo MS; Hemmerle H; Arnold FH
Chemistry; 2009 Nov; 15(43):11723-9. PubMed ID: 19774562
[TBL] [Abstract][Full Text] [Related]
11. Mechanism Underlying Conflicting Drug-Drug Interaction Between Aprepitant and Voriconazole via Cytochrome P450 3A4-Mediated Metabolism.
Ishida M; Kumagai T; Yamamoto T; Suzuki H; Moriki K; Fujiyoshi M; Nagata K; Shimada M
Yonago Acta Med; 2024 Feb; 67(1):31-40. PubMed ID: 38371278
[TBL] [Abstract][Full Text] [Related]
12. A dose-finding study to guide use of verapamil as an adjunctive therapy in tuberculosis.
Padmapriyadarsini C; Szumowski JD; Akbar N; Shanmugasundaram P; Jain A; Bathragiri M; Pattnaik M; Turuk J; Karunaianantham R; Balakrishnan S; Pati S; Agibothu Kupparam HK; Rathore MK; Raja J; Naidu KR; Horn J; Whitworth L; Sewell R; Ramakrishnan L; Swaminathan S; Edelstein PH
medRxiv; 2023 Aug; ():. PubMed ID: 37577511
[TBL] [Abstract][Full Text] [Related]
13. Complex Cytochrome P450 Kinetics Due to Multisubstrate Binding and Sequential Metabolism. Part 1. Theoretical Considerations.
Wang Z; Paragas EM; Nagar S; Korzekwa K
Drug Metab Dispos; 2021 Dec; 49(12):1090-1099. PubMed ID: 34503952
[TBL] [Abstract][Full Text] [Related]
14. Late Microaerobic Growth for Efficient Production of Human Cytochrome P450 3A4 in E. coli.
Marchetti L; Planchestainer M; Panke S; Held M
Chimia (Aarau); 2023 Jun; 77(6):417-423. PubMed ID: 38047781
[TBL] [Abstract][Full Text] [Related]
15. Rearrangement reactions catalyzed by cytochrome P450s.
Ortiz de Montellano PR; Nelson SD
Arch Biochem Biophys; 2011 Mar; 507(1):95-110. PubMed ID: 20971058
[TBL] [Abstract][Full Text] [Related]
16. QM/MM study of the active species of the human cytochrome P450 3A4, and the influence thereof of the multiple substrate binding.
Fishelovitch D; Hazan C; Hirao H; Wolfson HJ; Nussinov R; Shaik S
J Phys Chem B; 2007 Dec; 111(49):13822-32. PubMed ID: 18020326
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of machine learning models for cytochrome P450 3A4, 2D6, and 2C9 inhibition.
Gong C; Feng Y; Zhu J; Liu G; Tang Y; Li W
J Appl Toxicol; 2024 Mar; ():. PubMed ID: 38544296
[TBL] [Abstract][Full Text] [Related]
18. Optimization of the in vitro oxidative biotransformation of glimepiride as a model substrate for cytochrome p450 using factorial design.
Ruikar DB; Rajput SJ
Daru; 2012 Sep; 20(1):38. PubMed ID: 23351782
[TBL] [Abstract][Full Text] [Related]
19. REASSIGNMENT OF THE STRUCTURE OF A TRYPTOPHAN-CONTAINING CYCLIC TRIPEPTIDE PRODUCED BY THE BIARYLITIDE CROSSLINKING CYTOCHROME P450BLT.
Coe LJ; Zhao Y; Padva L; Keto A; Schittenhelm R; Tailhades J; Pierens G; Krenske EH; Crüsemann M; De Voss J; Cryle MJ
Chemistry; 2024 May; ():e202400988. PubMed ID: 38712638
[TBL] [Abstract][Full Text] [Related]
20. Correction to Leveraging Human Plasma-Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Cytochrome P450 3A4 by Modafinil.
Clin Pharmacol Ther; 2024 Feb; 115(2):372. PubMed ID: 38108195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
